Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 9/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18328169 | 0.87 | ABCG2 (0.42) | PTGS2P2RY14MGAMGAASI | |
| SCHEMBL20249064 | 0.81 | PTGS2 (0.47) | PTGS2P2RY14MGAMGAASI | |
| SCHEMBL20249065 | 0.79 | PTGS2 (0.49) | PTGS2P2RY14MGAMGAASI | |
| SCHEMBL20249059 | 0.79 | NPC1 (0.41) | GAANPC1LMNANFKB1RAB9A | |
| SCHEMBL29624418 | 0.78 | KEAP1 (0.46) | ABCG2CA12CA9MEN1KMT2A | |
| SCHEMBL20526107 | 0.78 | KEAP1 (0.46) | ABCG2CA12CA9MEN1KMT2A | |
| SCHEMBL20526096 | 0.77 | ABCG2 (0.40) | PTGS2P2RY14FLT3ABCG2CA12 | |
| SCHEMBL23302323 | 0.77 | RXRA (0.37) | LMNA | |
| SCHEMBL16867099 | 0.74 | DDR1 (0.36) | NPC1LMNANFKB1RAB9ANFKB2 | |
| SCHEMBL18327913 | 0.74 | NPC1 (0.43) | GAANPC1LMNANFKB1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180160686-A1 | DIARYLAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180160686-A1 | DIARYLAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | L3MBTL1, L3MBTL3, L3MBTL4 | PTGS2 4461/4885P2RY14 2505/4885MGAM 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.